Skip to content
Research Article Open access CC BY 4.0

Effectiveness and Safety of PDE5 Inhibitors for Men with Erectile Dysfunction Caused by Spinal Cord Injury

Yang Teng, Yu Dai, Zhongyun Ning, Ling Yao, Hui Ding, Baoyue Cao

Journal of Advances in Medicine and Medical Research · pp. 1–10 · Published 25 Apr 2016

10.9734/BJMMR/2016/24870

Abstract

Aims: The objective of this review was to assess the effectiveness of phosphodiesterase type 5 (PDE5) inhibitors in men with erectile dysfunction (ED) and spinal cord injury (SCI). Methodology: The following databases were sought up to May 2015: PubMed, Google scholar, EMBASE and Cochrane Library. We performed a meta-analysis of all available randomised controlled trials. We used odds ratios (ORs) to assess the strength of the association, and 95% confidence intervals (CIs) gave a sense of the precision of the estimate. Statistical analyses were performed by Review Manager, version 5.0. Results: After searching and screening the relevant articles, ten studies were included and assessed the effectiveness of PDE5 inhibitors in men with erectile dysfunction and spinal cord injury. The pooled results showed that sildenafil significantly improved erection compared with placebo in ED patients with SCI (OR = 5.96, 95% CI [3.36–10.55], P ＜ 0.00001) and there was no statistical difference compared incomplete injury group with complete injury group (OR = 0.73, 95% CI [0.38–1.43], P=0.36). It is evident that compared upper motor neuron with lower motor neuron, there were better responsive rates in sildenafil(OR = 11.56, 95% CI [2.88–46.36], P=0.0006). Because of lacking studies and data, we could not perform meta-analysis for other PDE5 inhibitors. The commonly reported adverse effects (AEs) were headache, flushing, dizziness and urinary tract infection in these studies. No severe adverse events were found. Conclusion: Current evidence suggests that sildenafil is effective treatment for ED patients with SCI. In future, we need more high quality randomized controlled trials (RCTs) to confirm these findings and evaluate the effectiveness of other PDE5 inhibitors.

PDE5 inhibitors erectile dysfunction spinal cord injury sildenafil

References (33)

  1. 1 Assessing the quality of reports of randomized clinical trials: Is blinding necessary? [DOI]
  2. 2 The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction [DOI]
  3. 3 Epidemiology, Demographics, and Pathophysiology of Acute Spinal Cord Injury [DOI]
  4. 4 Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? [DOI]
  5. 5 The Epidemiology of Traumatic Spinal Cord Injury in British Columbia, Canada [DOI]
  6. 6 Spinal Cord Injury Facts and Figures at a Glance [DOI]
  7. 7 Rehabilitation of spinal cord injury in France: a nationwide multicentre study of incidence and regional disparities [DOI]
  8. 8 Penile Prosthetic Surgery in Neurologically Impaired Patients: Long-Term Followup [DOI]
  9. 9 Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury [DOI]
  10. 10 Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men [DOI]
  11. 11 Bladder emptying over a period of 10–45 years after a traumatic spinal cord injury [DOI]
  12. 12 Efficacy and Safety of Tadalafil in Men With Erectile Dysfunction Following Spinal Cord Injury [DOI]
  13. 13 Vardenafil Improves Ejaculation Success Rates and Self-confidence in Men With Erectile Dysfunction due to Spinal Cord Injury [DOI]
  14. 14 Management of sexual dysfunction due to central nervous system disorders: a systematic review [DOI]
  15. 15 A Placebo-Controlled, Multicenter, Randomized, Double-Blind, Flexible-Dose,Two-Way Crossover Study to Evaluate the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction [DOI]
  16. 16 Erectile dysfunction in spinal cord-injured men: different treatment options [DOI]
  17. 17 Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury [DOI]
  18. 18 Quality of life in patients with spinal cord injury receiving VIAGRA® (sildenafil citrate) for the treatment of erectile dysfunction [DOI]
  19. 19 Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients [DOI]
  20. 20 Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries [DOI]
  21. 21 Efficacy and safety of sildenafil citrate (Viagra®) in men with erectile dysfunction and spinal cord injury: a review [DOI]
  22. 22 Specific aspects of erectile dysfunction in spinal cord injury [DOI]
  23. 23 Penile prostheses for the management of the neuropathic bladder and sexual dysfunction in spinal cord injury patients: long term follow up [DOI]
  24. 24 Sildenafil efficacy in erectile dysfunction secondary to spinal cord injury depends on the level of cord injuries [DOI]
  25. 25 Percutaneous Perineal Electrostimulation Induces Erection: Clinical Significance in Patients With Spinal Cord Injury and Erectile Dysfunction [DOI]
  26. 26 The Penile Erection Efficacy of a New Phosphodiesterase Type 5 Inhibitor, Mirodenafil (SK3530), in Rabbits with Acute Spinal Cord Injury [DOI]
  27. 27 Management of sexual disorders in spinal cord injured patients.
  28. 28 Male infertility and erectile dysfunction in spinal cord injury: A review [DOI]
  29. 29 Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury [DOI]
  30. 30 Up‐titration of vardenafil dose from 10 mg to 20 mg improved erectile function in men with spinal cord injury [DOI]
  31. 31 Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury [DOI]
  32. 32 Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients [DOI]
  33. 33 ABC of sexual health: Erectile dysfunction [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

56

Page views

0

PDF downloads

23

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.